Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WWE
876
DELISTED
World Wrestling Entertainment
WWE
| $4.75M | ﹤0.01% |
69,362
+14,656
| +27% | +$1.11M |
|
877
Equity Residential
EQR
$25B
| $4.74M | ﹤0.01% |
80,279
-84,685
| -51% | -$5.3M |
|
878
PPG Industries
PPG
$24.6B
| $4.74M | ﹤0.01% |
37,671
-18,347
| -33% | -$2.25M |
|
879
SBA Communications
SBAC
$19B
| $4.69M | ﹤0.01% |
16,729
-197,187
| -92% | -$54.9M |
|
880
Mettler-Toledo International
MTD
$29.1B
| $4.63M | ﹤0.01% |
3,210
+165
| +5% | +$221K |
|
881
Kinder Morgan
KMI
$70.8B
| $4.62M | ﹤0.01% |
255,727
-736,997
| -74% | -$13.3M |
|
882
Allstate
ALL
$68.3B
| $4.58M | ﹤0.01% |
33,811
-33,817
| -50% | -$4.42M |
|
|
ATCO
883
DELISTED
Atlas Corp.
ATCO
| $4.58M | ﹤0.01% |
+298,575
| New | +$4.51M |
|
884
Copart
CPRT
$27B
| $4.57M | ﹤0.01% |
150,130
-45,326
| -23% | -$1.36M |
|
885
Dow Inc
DOW
$21.6B
| $4.49M | ﹤0.01% |
89,021
-89,035
| -50% | -$4.35M |
|
886
Mattel
MAT
$4.42B
| $4.47M | ﹤0.01% |
250,671
+119,789
| +92% | +$2.17M |
|
887
Old Dominion Freight Line
ODFL
$44.1B
| $4.46M | ﹤0.01% |
31,418
-20,798
| -40% | -$2.95M |
|
|
GTM
888
ZoomInfo Technologies
GTM
$987M
| $4.41M | ﹤0.01% |
146,466
+54,664
| +60% | +$1.89M |
|
889
Campbell Soup
CPB
$6.56B
| $4.4M | ﹤0.01% |
77,505
-148,279
| -66% | -$7.78M |
|
890
TransDigm Group
TDG
$69.8B
| $4.4M | ﹤0.01% |
6,987
| – | – |
|
891
C4 Therapeutics
CCCC
$393M
| $4.36M | ﹤0.01% |
738,629
-898,865
| -55% | -$7.45M |
|
892
NiSource
NI
$21.4B
| $4.31M | ﹤0.01% |
157,293
+45,707
| +41% | +$1.2M |
|
893
American Water Works
AWK
$27B
| $4.3M | ﹤0.01% |
28,224
-16,238
| -37% | -$2.34M |
|
894
Vanguard Health Care ETF
VHT
$18.1B
| $4.28M | ﹤0.01% |
17,253
+14,587
| +547% | +$3.54M |
|
895
Idexx Laboratories
IDXX
$43.7B
| $4.27M | ﹤0.01% |
10,468
-10,470
| -50% | -$4.06M |
|
896
Fortinet
FTNT
$115B
| $4.24M | ﹤0.01% |
86,742
-209,584
| -71% | -$10.9M |
|
897
Ameriprise Financial
AMP
$48.4B
| $4.23M | ﹤0.01% |
13,576
-11,472
| -46% | -$3.5M |
|
|
CIIG
898
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
| $4.22M | ﹤0.01% |
414,175
+14,625
| +4% | +$147K |
|
|
SEPA
899
DELISTED
SEP Acquisition Corp Class A Common Stock
SEPA
| $4.21M | ﹤0.01% |
425,000
-25,000
| -6% | -$250K |
|
900
Dover
DOV
$27.5B
| $4.18M | ﹤0.01% |
30,889
-1,639
| -5% | -$218K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.